Health News Review
  • Jul 10 2013

    Some skeptical views of NYT front page “race for cholesterol drug” story

    A front-page story in the New York Times today, “Rare Mutation Ignites Race for Cholesterol Drug,” is worthy of further exploration. Any time the NYT puts a health/medical/science story on the front page, it probably warrants further exploration.   But I don’t think NYT front-page placement automatically warrants further front-page pickup by media across the [...]

    8 Comments
  • Jun 2 2013

    Colonoscopy: case study in 1st of NYT series on how economic incentives raise health care costs

    Noteworthy from the New York Times:  “The $2.7 Trillion Medical Bill: Colonoscopies Explain Why U.S. Leads the World in Health Expenditures.” Key excerpt: “While several cheaper and less invasive tests to screen for colon cancer are recommended as equally effective by the federal government’s expert panel on preventive care — and are commonly used in [...]

    2 Comments
  • Jun 1 2013

    “Here they go again” – 3 new proton beam facilities w/in 40 miles in DC-Baltimore

    “When it comes to reining in health care spending, it still seems like each hospital administrator thinks the guy at the other hospital should do it.”  That was the lead, as Jenny Gold of Kaiser Health News reports that two Washington,DC hospitals – three miles apart – are building expensive proton beam radiation centers for [...]

    4 Comments
  • May 28 2013

    5 shared decision-making articles in JAMA Internal Medicine receive little attention

    “Patient communication has room to grow,” reported Reuters Health.  And so does journalism about shared decision-making or patient-centered care – subject of four papers and an editorial in this week’s JAMA Internal Medicine. How Patient Centered Are Medical Decisions? Results of a National Survey “Respondents reported much more discussion of the pros than the cons [...]

    4 Comments
  • May 21 2013

    IMRT for prostate cancer: newer, costlier radiation no better than old

    HealthDay reports on a paper published in JAMA Internal Medicine: “The costly form of radiation therapy that has become the norm for prostate cancer in the United States may be no better than the older, cheaper variety — at least for some men, a new study suggests. Researchers found that among more than 1,000 U.S. [...]

    1 Comment
  • May 8 2013

    Medicare makes big news with big data dump on hospital charges

    The Washington Post Wonkblog:  “One hospital charges $8,000 – another, $38,000.” The piece contains an interactive graphic to allow readers to check on how much providers charge in their state.  And it used this graphic:   The Huffington Post:  “Hospital Prices No Longer Secret As New Data Reveals Bewildering System, Staggering Cost Differences.” Their graphic: [...]

    No Comments
  • Apr 16 2013

    Generic statins now “a market commodity, no different from grains of rice or sugar”

    Some drug stores in the US are now giving away statin drugs for cholesterol. The Philadelphia Inquirer reported on a chain in its area doing so: “Retail grocery store competition is fierce, and Wegmans is trying to get an edge by giving away – yes, free – a generic version of what was the world’s [...]

    No Comments
  • Apr 9 2013

    Urology journal publishes papers with questions about robots and proton beam therapy

    Probably the two most frequent subjects on this blog regarding the proliferation of new medical technologies are proton beam radiation therapy and robotic surgery.  Since this blog focuses on media messages about health care interventions, we generally focus on the marketing claims made for these technologies. The latest edition of the journal Current Urology Reports [...]

    No Comments
  • Feb 3 2013

    A few health care news gems from the past week that you may have missed

    The New Yorker profile of Dr. Oz, “The Operator: Is the most trusted doctor in America doing more harm than good?” The NPR piece, “Hanging A Price Tag On Radiology Tests Didn’t Change Doctors’ Habits.” PharmedOut.org’s new Drug Ads teaching tool.  It’s a three-part slideshow covering misleading advertising in  medical journals, indirect marketing, and disease-mongering; [...]

    No Comments
  • Jan 15 2013

    The media are influential…on everyone else, say Alzheimer’s specialists

    Nice catch by my colleague Andrew Holtz (one of our story reviewers on HealthNewsReview.org) as he combed the literature and settled on a paper in the Journal of Alzheimer’s Disease entitled, “Dementia Specialists and Early Adoption of Amyloid Imaging.”  With Andrew’s permission, I am reposting his piece in its entirety. ————————————————— A new survey of [...]

    1 Comment